Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the safety and efficacy of CCX140-B in adults with Type 2 Diabetes Mellitus; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CCX140-B (CCX140-B)

Snippet

Sponsor: Amgen | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED